Related Experiment Video
Updated: Jul 18, 2026

Intraductal Delivery and X-ray Visualization of Ethanol-Based Ablative Solution for Prevention and Local Treatment of Breast Cancer in Mouse Models
Published on: April 1, 2022
Prevention of breast cancer: current state of the science and future opportunities
1Breast Care Center, Department of Medicine, Baylor College of Medicine, Methodist Hospital, Houston, TX 77030, USA.
Abstract:
Despite significant progress in breast cancer treatment, mammary tumours still represent the second most frequent cause of cancer-related death in women in the US, with > 211,000 new cases in 2005; however, an expanding range of options for early diagnosis and more reliable risk assessment offers new alternatives for disease control by cancer prevention. Completed large studies with the classical selective estrogen receptor modulator (SERM) tamoxifen have demonstrated that preventing breast cancer pharmacologically is now possible. Novel SERMs, aromatase inhibitors and gonadotropin-releasing hormone agonists targeting hormonal pathways are being tested in clinical trials, revealing the potential for dramatic reductions in tumour incidence with minimal side effects; however, SERMs and aromatase inhibitors are effective only against estrogen receptor-positive tumours, thus chemopreventive drugs targeting other critical signalling pathways (such as retinoids, selective COX inhibitors and tyrosine kinase inhibitors) may provide a means to prevent estrogen receptor-negative breast cancer. In the future, hormonal and estrogen receptor-independent agents may be combined to prevent the development of all mammary tumours. This article reviews the current and novel strategies for breast cancer prevention.
Insights
Preventing breast cancer is possible through pharmacological interventions. New drugs target hormonal pathways and other signaling routes, offering hope for reducing tumor incidence with fewer side effects.
Area of Science:
- Oncology
- Pharmacology
- Preventive Medicine
Background:
- Breast cancer remains a leading cause of cancer death in women.
- Pharmacological prevention of breast cancer is now a reality, with tamoxifen as a key example.
- Advances in risk assessment and early diagnosis offer new avenues for disease control.
Purpose of the Study:
- To review current and novel strategies for breast cancer prevention.
- To explore the potential of targeting hormonal and other signaling pathways for chemoprevention.
- To discuss the development of agents for both estrogen receptor-positive and -negative breast cancers.
Main Methods:
- Review of completed large studies on selective estrogen receptor modulators (SERMs).
- Analysis of ongoing clinical trials for novel SERMs, aromatase inhibitors, and gonadotropin-releasing hormone agonists.
- Exploration of chemopreventive agents targeting non-hormonal pathways, including retinoids, COX inhibitors, and tyrosine kinase inhibitors.
Main Results:
- Selective estrogen receptor modulators (SERMs) and aromatase inhibitors are effective for estrogen receptor-positive tumors.
- Novel hormonal agents show potential for significant tumor incidence reduction with minimal side effects.
- Emerging agents targeting other signaling pathways may prevent estrogen receptor-negative breast cancer.
Conclusions:
- Pharmacological breast cancer prevention is an evolving field with diverse therapeutic strategies.
- Future prevention efforts may involve combining hormonal and estrogen receptor-independent agents.
- Continued research into novel chemopreventive agents is crucial for comprehensive breast cancer control.
More Related Videos
12:57X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models
Published on: December 9, 2022
13:04In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
Published on: October 14, 2015
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Preventive Healthcare Services
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Cancer Survival Analysis